Ordering from the Americas?Switch to the US store
We don't ship to your country yet. We ship across Europe and the Americas. You can keep browsing.

Peptency Academy · Compound

Epitalon (epithalon, Ala-Glu-Asp-Gly)

Epitalon, also written epithalon, is the tetrapeptide Ala-Glu-Asp-Gly. Source sentencePubChem title: Epitalon. Catalog chemistry record: name Epitalon, also known as Epithalon, sequence Ala-Glu-Asp-Gly, length 4.1 PubChem CID 2190422 Peptency catalog chemistry record, Epitalon A 2025 review in the International Journal of Molecular Sciences, titled as an overview of epitalon as a pineal tetrapeptide, covers in vitro, in vivo and in silico studies of epitalon. Source sentencePubMed title: "Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties." Measured: overview of in vitro, in vivo and in silico studies of epitalon.3 Int J Mol Sci 2025 PubChem records epitalon under CID 219042: formula C14H22N4O9, about 390.35 Da, CAS 307297-39-8. Source sentenceTitle: Epitalon; MolecularFormula: C14H22N4O9; MolecularWeight: 390.35; CAS: 307297-39-81 PubChem CID 219042

Research at a glance

Of the 3 primary studies on Epitalon reviewed here, all are lab or animal studies; none is in humans.

Most human model studied
Animal studies
Studies reviewed
3: 2 lab, 1 animal
Registered trials
0
EMA
No authorisation found
WADA
Not named

Status records

Version 1Edited Evidence through 12 sources

Regulatory content shown for: EU and UK.

Tetrapeptide, 4 residues

  • Catalog recordEpitalon4 residuesabout 390.35 DaSource sentenceTitle: Epitalon; MolecularFormula: C14H22N4O9; MolecularWeight: 390.35; CAS: 307297-39-81 PubChem CID 219042

Known, not known, contested

Known

  • The formula computed from the catalog sequence, C14H22N4O9, matches the formula PubChem records, and PubChem confirms the CAS number 307297-39-8 for CID 219042. Source sentenceCatalog chemistry record cross check (5 Oct 2026): formulaFromSequence C14H22N4O9; PubChem formula C14H22N4O9; casConfirmedByPubChem true.1 PubChem CID 2190422 Peptency catalog chemistry record, Epitalon
  • A 2003 lifelong study in female mice measured biomarkers of ageing, lifespan and spontaneous tumour incidence after epitalon. Source sentencePubMed title: "Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice." Measured: lifelong study in female mice of epitalon on biomarkers of ageing, lifespan and spontaneous tumour incidence.4 Biogerontology 2003
  • A 2004 study in human fetal fibroblasts examined cell division and telomerase after exposure to epithalon. Source sentencePubMed title: "Peptide promotes overcoming of the division limit in human somatic cell." Measured: studied proliferative potential and telomerase in human fetal fibroblasts exposed to epithalon.5 Bull Exp Biol Med 2004
  • A 2025 study measured telomere length and telomerase activity in human cell lines exposed to epitalon. Source sentencePubMed title: "Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity." Measured: telomere length and telomerase activity in human cell lines exposed to epitalon.6 Biogerontology 2025

Not known

Contested

Nothing listed yet.

Chemistry: Epitalon as PubChem CID 219042 records it

Sequence
AEDG
Length
4 residues
Formula
C14H22N4O9
Average mass
390.35 Da
CAS
307297-39-8
PubChem CID
219042
Synonyms
Epithalon, Epitalon
Salt form
No salt form stated in the record
Checked 5 October 2026 1 PubChem CID 219042

Sequence

AEDG

Ala-Glu-Asp-Gly, the 4 residues of Epitalon as the catalog record gives them.

Published literature

  • On 5 Oct 2026 PubMed held 140 records matching Epitalon by title and abstract, of which 1 carry the clinical trial publication type and 14 the review type. This page reads 4 of them. Source sentencePubMed record count for the query (epitalon[tiab] OR epithalon[tiab] OR "Ala-Glu-Asp-Gly"[tiab]): 140; with clinical trial[pt]: 1; with review[pt]: 14.10 PubMed search for Epitalon, 5 October 2026

Studies

  1. RodentBiogerontology 2003

    Lifelong study in female mice of epitalon on biomarkers of ageing, lifespan and spontaneous tumour incidence.

    Design
    Animal study
    Population or model
    female Swiss-derived SHR mice
    Molecule
    Epitalon exact

    PubMed 14501183DOI

  2. In vitro or ex vivoBiogerontology 2025

    Measured telomere length and telomerase activity in human cell lines exposed to epitalon.

    Design
    In vitro
    Population or model
    human cell lines
    Molecule
    Epitalon exact

    PubMed 40908429DOIcorrection: 41240216

  3. In vitro or ex vivoInt J Mol Sci 2025

    Overview of in vitro, in vivo and in silico studies of epitalon.

    Design
    Review
    Molecule
    Epitalon exact

    PubMed 40141333DOI

  4. In vitro or ex vivoBull Exp Biol Med 2004

    Studied proliferative potential and telomerase in human fetal fibroblasts exposed to epithalon.

    Design
    In vitro
    Population or model
    human fetal fibroblasts
    Molecule
    Epithalon exact

    PubMed 15455129DOI

Cell culture studies and review

  • Cell culture studies of 2004 and 2025 measured telomerase activity, telomere length and proliferative potential in human cells exposed to epitalon. Source sentenceMeasured per the PubMed records: proliferative potential and telomerase in human fetal fibroblasts exposed to epithalon; telomere length and telomerase activity in human cell lines exposed to epitalon.5 Bull Exp Biol Med 20046 Biogerontology 2025
  • A 2025 review covers in vitro, in vivo and in silico studies of epitalon. Source sentenceMeasured: overview of in vitro, in vivo and in silico studies of epitalon.3 Int J Mol Sci 2025

Status matrix

European Union: EMA records

EU

  • No centrally authorised procedure in the EMA medicines data of 5 Oct 2026 names epitalon as an active substance. National authorisations are not in that dataset. Source sentenceEMA medicines JSON report, snapshot 2026-10-05T06:02:03Z: 0 procedures for epitalon; control lookup (semaglutide): 5 procedures.9 EMA medicines data, 5 October 2026

United Kingdom: MHRA records

UK

  • No SmPC, PIL or PAR document in MHRA Products matches the exact name epitalon on 5 Oct 2026. Source sentenceMHRA Products search for the exact name "epitalon" over SmPC, PIL and PAR documents: 0 documents; control lookup (semaglutide): 271 documents.11 MHRA Products search for epitalon, 5 October 2026

Sport anti-doping list

International

  • The WADA 2026 Prohibited List, in force from 1 Jan 2026, does not name this substance. The list names substances by example, so this is not a statement that it is permitted in sport. Source sentenceWADA 2026 Prohibited List text search for Epitalon and its alternative names: no entry; list in force 1 January 2026.12 WADA Prohibited List 2026

Registry records

Integrity notes

  • PubMed lists an erratum for the 2025 cell line paper on telomere length (PMID 40908429): Biogerontology, 15 Nov 2025, 27(1):1. The paper itself is listed here with that note. Source sentencePubMed efetch CommentsCorrections for PMID 40908429: ErratumIn, Biogerontology. 2025 Nov 15;27(1):1. doi: 10.1007/s10522-025-10326-8 (PMID 41240216).6 Biogerontology 2025
  • The PubMed records read for the other three studies on this page list no correction, retraction or expression of concern (checked 5 Oct 2026). Source sentencePubMed efetch CommentsCorrections for PMIDs 14501183, 40141333 and 15455129: none of type ErratumIn, RetractionIn or ExpressionOfConcernIn.10 PubMed search for Epitalon, 5 October 2026

Other compounds in the Academy

Chemistry and records

Epitalon: sequence, mass, CAS and regulatory record in the research library →

Sources

  1. 1PubChem CID 219042 accessed 5 Oct 2026
  2. 2Peptency catalog chemistry record, Epitalon accessed 5 Oct 2026
  3. 3Int J Mol Sci 2025 accessed 5 Oct 2026
  4. 4Biogerontology 2003 accessed 5 Oct 2026
  5. 5Bull Exp Biol Med 2004 accessed 5 Oct 2026
  6. 6Biogerontology 2025 accessed 5 Oct 2026
  7. 7ClinicalTrials.gov search for Epitalon, 5 October 2026 accessed 5 Oct 2026
  8. 8openFDA Drugs@FDA query for epitalon and epithalon, 5 October 2026 accessed 5 Oct 2026
  9. 9EMA medicines data, 5 October 2026 accessed 5 Oct 2026
  10. 10PubMed search for Epitalon, 5 October 2026 accessed 5 Oct 2026
  11. 11MHRA Products search for epitalon, 5 October 2026 accessed 5 Oct 2026
  12. 12WADA Prohibited List 2026 accessed 5 Oct 2026

About this page

Research-use information. This library summarises published literature and regulator records. It is not guidance for use, not medical advice, and not a statement that any material is suitable for use in people or animals.

Drafted from the verified research library records and passed the Academy schema, cross reference and wording checks. The seven checker rounds used on the earlier compound pages have not been run on this page.. Version 1, edited 16 November 2026, 12 sources.

Cite this page: Peptency Academy. Epitalon: tetrapeptide chemistry, studies and status. Version 1./eu/academy/compounds/epitalon/